Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Operations and Strategic Initiatives
DVA logo

DaVita Controls 36% of U.S. Dialysis Market and Repurchases $1.7 Billion in Stock

DVA10-KFiling Date: 2/11/2026
DaVita Inc.
Description

What this story covers

DaVita Inc. maintains a dominant 36% U.S. dialysis market share while navigating rising labor costs and shifting to value-based care. Despite flat treatment volumes, the company remains focused on international expansion and aggressive share repurchases.

Story snapshot

CompanyDaVita Inc.
TickerDVA
VariantStandard detailed
Duration11:17
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0000927066-26-000012
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in